Mr. Piazza joined Orbital Therapeutics in January 2023 and is a seasoned biotech executive and finance professional with more than 20 years of experience in biotech, healthcare investment banking, finance, and large pharma roles. He most recently served as CFO of Silverback Therapeutics and helped orchestrate its IPO, and later its reverse merger with ARS Pharma. As a healthcare banker at Goldman Sachs, Barclays Capital, and Lehman Brothers, he has advised on approximately $100 billion in biopharma and life sciences financing and strategic transactions across both large and small companies. Previously, he was a financial advisor at Smith Barney (now Morgan Stanley Smith Barney), and prior to that, he worked in engineering, development, and international marketing disciplines at Abbott Laboratories across multiple divisions of the company. Mr. Piazza earned a Bachelor of Science degree in Chemical Engineering from The Ohio State University and an MBA from the Haas School of Business at the University of California at Berkeley.